Skip to main content
NASDAQ:FUSN

Fusion Pharmaceuticals Insider Trades

$8.59
+0.15 (+1.78 %)
(As of 05/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.27
▼
$8.95
50-Day Range
$8.33
▼
$11.95
52-Week Range
$8.09
▼
$19.00
Volume26,317 shs
Average Volume46,383 shs
Market Capitalization$364.60 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Insider Trades

Fusion Pharmaceuticals (NASDAQ:FUSN) Insider Buying and Selling Activity

Insider Buying (Last 12 Months): $12,325,000.00
Insider Selling (Last 12 Months): $56,609.91

Insider Buying and Selling by Quarter


Fusion Pharmaceuticals (NASDAQ FUSN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2020Adams Street Partners LlcMajor ShareholderSell4,569$12.39$56,609.91  
6/30/2020Johnson & JohnsonMajor ShareholderBuy725,000$17.00$12,325,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 5/12/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.